Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop the memory-destroying disease. Around 145,000 people in the UK hav… ...

Common cough medicine could slow dementia in Parkinson’s patients, study hints Cough medicine widely used in Europe remains unapproved for use in US, Canada, researchers say Vishwam Sankaran ...

Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...

Medical associations sue U.S. health leaders over COVID-19 vaccine restrictions, citing concerns about public health, vaccine ...

Rentosertib, an AI-generated small molecule targeting Traf2- and Nck-interacting kinase, was safe and improved FVC in ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Regular mucus tends to be thin and slippery, and it is generally a constant presence on a day-to-day basis. Meanwhile, phlegm ...

Lack of testing accounts for the highest number of patients lost in the TB care cascade, and stigma keeps many patients from ...